Literature DB >> 8138866

Methods of evaluating methylphenidate in children with attention deficit hyperactivity disorder: acceptability, satisfaction, and compliance.

C Johnston1, S Fine.   

Abstract

Compared two methods of evaluating methylphenidate (MPH) on measures of parental acceptance, satisfaction, and compliance with the treatment. Twenty-four 6- to 10-year-old children with Attention Deficit Hyperactivity Disorder (ADHD) were randomly assigned to either a blind, placebo-controlled medication trial (MT) or to a typical clinical procedures (TCP) evaluation that was nonblind and without a placebo control. Ratings of satisfaction were significantly higher in the MT condition than in the TCP condition; however, all parents became more accepting of MPH after participating in an evaluation. Both during the evaluation and at 6-week and 3-month follow-ups, approximately 20% of cases were not complying with treatment. However, rates of compliance did not differ between the MT and TCP conditions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8138866     DOI: 10.1093/jpepsy/18.6.717

Source DB:  PubMed          Journal:  J Pediatr Psychol        ISSN: 0146-8693


  16 in total

Review 1.  Parental preferences and goals regarding ADHD treatment.

Authors:  Alexander G Fiks; Stephanie Mayne; Elena Debartolo; Thomas J Power; James P Guevara
Journal:  Pediatrics       Date:  2013-09-02       Impact factor: 7.124

2.  Use of double-blind placebo-controlled N-of-1 trials among stimulant-treated youths in The Netherlands: a descriptive study.

Authors:  Adrianne Faber; Ron J Keizer; Paul B van den Berg; Lolkje T W de Jong-van den Berg; Hilde Tobi
Journal:  Eur J Clin Pharmacol       Date:  2006-11-18       Impact factor: 2.953

3.  Medication refusal in children with oppositional defiant disorder or conduct disorder and comorbid attention-deficit/hyperactivity disorder: medication history and clinical correlates.

Authors:  Mark Demidovich; David J Kolko; Oscar G Bukstein; Jonathan Hart
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-02-02       Impact factor: 2.576

4.  Mothers' and children's perceptions of medication for children with attention-deficit hyperactivity disorder.

Authors:  R E McNeal; M C Roberts; V J Barone
Journal:  Child Psychiatry Hum Dev       Date:  2000

5.  Evaluation of attitudes towards treatment in adolescents with attention deficit hyperactivity disorder (ADHD).

Authors:  Maite Ferrin; Miguel Ruiz-Veguilla; Maria Blanc-Betes; Samaa El Abd; Teresa Lax-Pericall; Maxine Sinclair; Eric Taylor
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-06-20       Impact factor: 4.785

Review 6.  Promoting productive interactions between parents and physicians in the treatment of children with attention-deficit/hyperactivity disorder.

Authors:  William B Brinkman; Jeffery N Epstein
Journal:  Expert Rev Neurother       Date:  2011-04       Impact factor: 4.618

7.  Participant satisfaction in a study of stimulant, parent training, and risperidone in children with severe physical aggression.

Authors:  E Victoria Rundberg-Rivera; Lisa D Townsend; Jayne Schneider; Cristan A Farmer; Brooke B S G Molina; Robert L Findling; Kenneth D Gadow; Oscar G Bukstein; L Eugene Arnold; David J Kolko; Kristin A Buchan-Page; Nora K McNamara; Chenel Michel; Adrienne Austin; Heidi Kipp; Robert R Rice; Michael G Aman
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-04       Impact factor: 2.576

8.  European clinical guidelines for hyperkinetic disorder -- first upgrade.

Authors:  Eric Taylor; Manfred Döpfner; Joseph Sergeant; Philip Asherson; Tobias Banaschewski; Jan Buitelaar; David Coghill; Marina Danckaerts; Aribert Rothenberger; Edmund Sonuga-Barke; Hans-Christoph Steinhausen; Alessandro Zuddas
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

9.  Drug and placebo side effects in methylphenidate-placebo trial for attention deficit hyperactivity disorder.

Authors:  S Fine; C Johnston
Journal:  Child Psychiatry Hum Dev       Date:  1993

10.  Implementing the American Academy of Pediatrics attention-deficit/hyperactivity disorder diagnostic guidelines in primary care settings.

Authors:  Laurel K Leslie; Jill Weckerly; Dena Plemmons; John Landsverk; Sarita Eastman
Journal:  Pediatrics       Date:  2004-07       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.